Key facts
- This page summarizes Stephen Gordon's Form 4 filing for TransMedics Group, Inc. (TMDX).
- 7 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 02 Feb 2024, 18:56.
Stephen Gordon - 01 Feb 2024 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- TMDX
- Reported as of
- 01 Feb 2024
- Net transaction value
- -$1,008,599
- SEC form
- 4
- Accepted by SEC
- 02 Feb 2024, 18:56:07 UTC
- Prior SEC filing
- 03 Jan 2024
- Next SEC filing
- 27 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Stephen Gordon
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stephen Gordon filed Form 4 for TransMedics Group, Inc. (TMDX) on 02 Feb 2024.
Change
- Previous filing in this sequence was filed on 03 Jan 2024.
- Current net transaction value: -$1,008,599.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMDX
transaction
Common Stock
Options Exercise
- Transaction value
- $117,302
- Shares
- +8,833
- Change %
- +68%
- Price
- $13.28
- Shares after
- 21,908
- Date
- 01 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
TMDX
transaction
Common Stock
Options Exercise
- Transaction value
- $58,814
- Shares
- +3,644
- Change %
- +17%
- Price
- $16.14
- Shares after
- 25,552
- Date
- 01 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
TMDX
transaction
Common Stock
Options Exercise
- Transaction value
- $97,035
- Shares
- +2,523
- Change %
- +9.9%
- Price
- $38.46
- Shares after
- 28,075
- Date
- 01 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
TMDX
transaction
Common Stock
Sale
- Transaction value
- $1,281,750
- Shares
- -15,000
- Change %
- -53%
- Price
- $85.45
- Shares after
- 13,075
- Date
- 01 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -8,833
- Change %
- -24%
- Price
- $0.000000
- Shares after
- 28,167
- Date
- 01 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,833
- Exercise price
- $13.28
- Footnotes
- F1, F3
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,644
- Change %
- -64%
- Price
- $0.000000
- Shares after
- 2,084
- Date
- 01 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,644
- Exercise price
- $16.14
- Footnotes
- F1, F4
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,523
- Change %
- -3.6%
- Price
- $0.000000
- Shares after
- 67,477
- Date
- 01 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,523
- Exercise price
- $38.46
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 14, 2023.
Footnote F2
Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F3
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.
Footnote F4
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 27, 2024.
Footnote F5
The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 24, 2025.